Literature DB >> 11254566

Preexposure of murine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge.

T D Crabtree1, L Jin, D P Raymond, S J Pelletier, C W Houlgrave, T G Gleason, T L Pruett, R G Sawyer.   

Abstract

Bacterial DNA and synthetic oligonucleotides containing CpG sequences (CpG-DNA and CpG-ODN) provoke a proinflammatory cytokine response (tumor necrosis factor alpha [TNF-alpha], interleukin-12 [IL-12], and IL-6) and increased mortality in lipopolysaccharide (LPS)-challenged mice via a TNF-alpha-mediated mechanism. It was hypothesized that preexposure of macrophages to CpG-ODN would result in an increased TNF-alpha response to subsequent LPS challenge in vitro. Using the murine macrophage cell line RAW 264.7, we demonstrated both a rapid proinflammatory cytokine response (TNF-alpha) and a delayed inhibitory cytokine response (IL-10) with CpG-ODN. Preexposure of macrophages to CpG-ODN for brief periods (1 to 3 h) augmented TNF-alpha secretion and mRNA accumulation following subsequent LPS challenge (1 microg/ml). However, prolonged preexposure to CpG-ODN (6 to 9 h) resulted in suppression of the TNF-alpha protein and mRNA response to LPS. The addition of anti-IL-10 antibody to CpG-ODN during preexposure resulted in an increase in the LPS-induced TNF-alpha response over that induced by CpG-ODN preexposure alone. Thus, while brief preexposure of macrophages to CpG-ODN augments the proinflammatory cytokine response to subsequent LPS challenge, prolonged preexposure elicits IL-10 production, which inhibits the TNF-alpha response. Although the initial proinflammatory effects of CpG-DNA are well established, the immune response to CpG-DNA may also include autocrine or paracrine feedback mechanisms, leading to a complex interaction of proinflammatory and inhibitory cytokines.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11254566      PMCID: PMC98138          DOI: 10.1128/IAI.69.4.2123-2129.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  35 in total

1.  Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages.

Authors:  J J Gao; E G Zuvanich; Q Xue; D L Horn; R Silverstein; D C Morrison
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

Review 2.  Mechanisms and applications of immune stimulatory CpG oligodeoxynucleotides.

Authors:  A M Krieg
Journal:  Biochim Biophys Acta       Date:  1999-12-10

Review 3.  Use of CpG DNA for enhancing specific immune responses.

Authors:  H L Davis
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

4.  Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.

Authors:  G Hartmann; R D Weeratna; Z K Ballas; P Payette; S Blackwell; I Suparto; W L Rasmussen; M Waldschmidt; D Sajuthi; R H Purcell; H L Davis; A M Krieg
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

Review 5.  Advances in vaccine adjuvants.

Authors:  M Singh; D O'Hagan
Journal:  Nat Biotechnol       Date:  1999-11       Impact factor: 54.908

6.  Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression.

Authors:  F Nomura; S Akashi; Y Sakao; S Sato; T Kawai; M Matsumoto; K Nakanishi; M Kimoto; K Miyake; K Takeda; S Akira
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

7.  Cutting edge: cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages.

Authors:  S Akashi; R Shimazu; H Ogata; Y Nagai; K Takeda; M Kimoto; K Miyake
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

8.  CpG DNA overcomes hyporesponsiveness to hepatitis B vaccine in orangutans.

Authors:  H L Davis; I I Suparto; R R Weeratna; D D Iskandriati; S S Chamzah; A A Ma'ruf; C C Nente; D D Pawitri; A M Krieg; W Smits; D D Sajuthi
Journal:  Vaccine       Date:  2000-03-17       Impact factor: 3.641

9.  IL-10 inhibits cytokine production by activated macrophages.

Authors:  D F Fiorentino; A Zlotnik; T R Mosmann; M Howard; A O'Garra
Journal:  J Immunol       Date:  1991-12-01       Impact factor: 5.422

10.  Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA.

Authors:  J P Messina; G S Gilkeson; D S Pisetsky
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

View more
  12 in total

1.  Use of locked nucleic acid oligonucleotides to add functionality to plasmid DNA.

Authors:  Kirsten M L Hertoghs; Jonathan H Ellis; Ian R Catchpole
Journal:  Nucleic Acids Res       Date:  2003-10-15       Impact factor: 16.971

2.  Strain-specific effects of probiotics on gut barrier integrity following hemorrhagic shock.

Authors:  Misha D Luyer; Wim A Buurman; M'hamed Hadfoune; Gea Speelmans; Jan Knol; Jan A Jacobs; Cornelis H C Dejong; Aldwin J M Vriesema; Jan Willem M Greve
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance.

Authors:  Alexander H Dalpke; Martin D Lehner; Thomas Hartung; Klaus Heeg
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

4.  Intratumoral immunotherapy relies on B and T cell collaboration.

Authors:  Idit Sagiv-Barfi; Debra K Czerwinski; Tanaya Shree; Julian J K Lohmeyer; Ronald Levy
Journal:  Sci Immunol       Date:  2022-05-27

5.  Exposure to bacterial DNA before hemorrhagic shock strongly aggravates systemic inflammation and gut barrier loss via an IFN-gamma-dependent route.

Authors:  Misha D Luyer; Wim A Buurman; M'hamed Hadfoune; T Wolfs; Cornelis van't Veer; Jan A Jacobs; Cornelis H Dejong; Jan Willem M Greve
Journal:  Ann Surg       Date:  2007-05       Impact factor: 12.969

6.  CpG DNA prevents liver injury and shock-mediated death by modulating expression of interleukin-1 receptor-associated kinases.

Authors:  Young-In Kim; Jeoung-Eun Park; Antonio Martinez-Hernandez; Ae-Kyung Yi
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

7.  Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology.

Authors:  Terianne M Wong; Nikolai Petrovsky; Stephanie J Bissel; Clayton A Wiley; Ted M Ross
Journal:  Hum Vaccin Immunother       Date:  2016-05-24       Impact factor: 3.452

8.  The counter regulatory response induced by CpG oligonucleotides prevents bleomycin induced pneumopathy.

Authors:  Takeshi Kinjo; Koji Tomaru; Diana C Haines; Dennis M Klinman
Journal:  Respir Res       Date:  2012-06-18

9.  Immunomodulatory mechanisms of lactobacilli.

Authors:  Jerry M Wells
Journal:  Microb Cell Fact       Date:  2011-08-30       Impact factor: 5.328

10.  XIAP regulates cytosol-specific innate immunity to Listeria infection.

Authors:  Laura D Bauler; Colin S Duckett; Mary X D O'Riordan
Journal:  PLoS Pathog       Date:  2008-08-29       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.